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Summary
Background: Spontaneous spondylodiscitis is an uncommon disease, which may result in serious
complications with potentially high morbidity and mortality. We conducted a prospective case
study over a 2-year period in order to analyze the clinical features, approaches to management,
and outcome of spondylodiscitis.
Methods: Eight consecutive patients (four men, four women; age range 53—82 years) suffering
from spondylodiscitis were identified during the study period. Parameters recorded included:
demographics, past medical history, predisposing factors, presenting signs and symptoms, spinal
level and extension of the infection, laboratory indices of inflammation, microbiological testing,
radiological assessment, kind and duration of treatment, follow-up magnetic resonance imaging
(MRI) studies, and outcome.
Results: Duration of symptoms varied from 14 to 90 days. All patients had back pain; fever38 8C
was present in 5/8 (62.5%) and neurological findings in 6/8 (75%). Diabetes mellitus was identified
in six (75%). Most of the patients had elevated laboratory markers of inflammation. At the initial
MRI, 12 anatomical levels were found. The microorganism was identified in 7/8 by blood or bone
marrow cultures (50% Staphylococcus aureus). None of the patients underwent surgical inter-
vention. Seven patients (87.5%) recovered to full activity; follow-up MRI study results were not
always in parallel with the clinical improvement of patients.
Conclusions: Spontaneous spondylodiscitis should be considered in every patient with back pain
accompanied by fever and laboratory markers of inflammation. Themajor predisposing risk factor
seems to be uncontrolled diabetes. MRI appears to be the method of choice for confirming
§ This work was presented in part as an abstract at the 32nd Congress of the European Society of Neuroradiology, Genoa, Italy, September 21—
23, 2007; Neuroradiology 2007;49(Suppl 2):S127.
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diagnosis. Timely and accurate diagnosis along with prompt administration of antibiotics appears
mandatory for a favorable outcome and avoidance of surgical intervention.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Infectious spondylodiscitis, or septic discitis, is an uncommon
infectious condition in which symptoms may be non-specific,
including fever, local tenderness, and neurological signs
when deformity of the affected structures has developed.1,2
The course may be acute or chronic, but the lack of specific
symptoms usually results in delayed diagnosis leading to
potentially high morbidity and mortality.3 In most cases
the affected patients have one or more predisposing under-
lying conditions, such as diabetes mellitus, alcoholism, HIV
infection, a spinal abnormality or intervention, or a potential
local or systemic source of infection.3,4
The aim of the present prospective study was to deter-
mine the whole spectrum of spondylodiscitis, including the
clinical manifestations of the disease, the underlying risk
factors, and the diagnostic work-up required to reach a
timely and correct diagnosis, as well as the management,
follow-up, and the outcome of a consecutive series of eight
patients who were admitted to the Department of Medicine
of the Medical School, University of Thessaly, Central Greece
over a 2-year period (2005—2007).
Materials and methods
During the study period we identified eight patients with
spontaneous spondylodiscitis. Diagnosis was based on clinical
presentation, high laboratory indices of inflammation (white
blood cell count (WBC), erythrocyte sedimentation rate
(ESR), and C-reactive protein (CRP)), and identification of
the causative organism from blood or bone marrow cultures,
confirmed by magnetic resonance imaging (MRI) findings.Table 1 Epidemiological and clinical data of patients at present
Patient Sex Age
(years)
Initial
prevailing
symptom
Fever
(38 8C)
Local spine
sensitivity
Durat
sympt
days
1 F 53 Back pain No Yes 90
2 M 82 Back pain Yes Yes 30
3 M 65 Back pain Yes Yes 20
4 F 59 Back pain No Yes 14
5 M 82 Back pain No No 45
6 F 63 Back pain Yes Yes 45
7 M 57 Back pain Yes Yes 40
8 F 63 Back pain Yes Yes 20
M, male; F, female; CHD, coronary heart disease; COPD, chronic obstruct
anti-inflammatory drugs.
a One or more of the following symptoms: back pain, fever, chills, ri
muscle weakness of the lower limbs.Demographic, clinical, laboratory, and radiological data
were collected prospectively for each case. Themanagement
of the disease and clinical, laboratory, and MRI follow-up
studies of the patients were also recorded. MRI findings
suggestive of spondylodiscitis included increased signal of
the intervertebral disc on T2 images, vertebral body marrow
edema, vertebral body and disc enhancement, epidural or
paraspinal inflammation, and canal compromise. At the fol-
low-up MRI studies performed 4—6 weeks after the initial
MRI, imaging characteristics were categorized as improved,
unchanged, or worsened compared to the initial study. The
ethics committee of the Medical School, University of Thes-
saly, approved the study protocol.
Results
Patient characteristics
The epidemiological and clinical data of the patients are
shown in Table 1. Seven patients had been treated with
analgesics, while two had received antibiotic treatment.
One patient (patient 4) developed catastrophic antipho-
spholipid syndrome.5,6 Physical examination revealed neu-
rological findings in six patients, namely decreased
sensation below the spinal level of infection, decreased
tendon reflexes of the lower limbs, and Lasegue’s sign. None
of the patients was under immunosuppression, had chronic
spinal disease, history of chronic back pain, or had under-
gone any spinal surgical procedure in the past. Diabetes
mellitus was defined as uncontrolled in all six diabetic
patients as attested by the high concentrations of glycosy-
lated hemoglobin A1.ation.
ion of
oms,a
Diabetes
mellitus
Underlying
condition
Previous treatment
Yes Scabies NSAIDs, antibiotics
Yes Squamous cell
carcinoma, CHD
Antibiotics
Yes CHD, hypertension NSAIDs
Yes Hypertension NSAIDs
No Hypertension, COPD,
benign prostatic
hyperplasia
NSAIDs
Yes Asthma NSAIDs
Yes Hypertension NSAIDs
No Decompensated Paracetamol
HCV-related cirrhosis
ive pulmonary disease; HCV, hepatitis C virus; NSAIDs, non-steroidal
gor, sweats, dyspnea, anorexia, weight loss, arthralgias, proximal
Table 2 Laboratory data, causative agents, MRI findings, treatment, and follow-up of the patients with spondylodiscitis.
Patient Initial laboratory data Laboratory data at
discharge
Causative
agent
Level of
lesions
T2 SI
increase
DE BM VB Gado+ Management Pain
relief
(days)
Mobilization
(days)
Follow-up
MRI (4—6
weeks)
WBC
(109/l)
CRP
(mg/dl)
ESR
(mm/1h)
WBC
(109/l)
CRP
(mg/dl)
ESR
(mm/1h)
1 13.3 19.7 79 5.2 0.9 15 Undefined T10—11 + + + + Vancomycin IV
(45 days); oral
ciprofloxacin + rifampin
for 6 months
33 45 Improved
2 4.9 19.7 61 5.1 0.9 21 Staphylococcus
aureus
L1—2 +  + + Teicoplanin IV
(42 days); oral
ciprofloxacin + rifampin
for 7 months
16 70 Stable
T9—10 +    Improved
3 9.3 6.9 83 8.6 3.0 35 Brucella
melitensis
T12—L1   + + Streptomycin IM
(21 days) + oral
rifampin + doxycycline
for 2 months
30 14 Stable
L4—5 +  +  Stable
4 29.8 35 119 5.9 3.1 48 Staphylococcus
aureus
T11—12 + + + + Teicoplanin IV
(90 days); oral
ciprofloxacin for
15 months
17 73 Improved
L4—5 + + + + Stable
5 7.1 9.9 61 6.9 2.8 21 Pseudomonas
aeruginosa
T6—7  + + + Ticarcillin/clavulanic
acid IV
(45 days); oral
ciprofloxacin for 10 months
14 42 Stable
T11—12 + + + + Stable
6 19.1 28 63 5.9 0.8 23 Staphylococcus
aureus
L3—4 + +  + Vancomycin IV
(45 days); oral
ciprofloxacin + rifampin
for 10 months
15 30 Worseneda
7 10.6 3.7 47 4.9 0.1 22 Staphylococcus
aureus
L3—4 + + + + Vancomycin IV
(42 days); oral
ciprofloxacin +
rifampin for 7 months
10 20 Improved
8 30.7 2.3 12 2.9 0.1 14 Enterococcus
faecalis
and Escher
ichia coli
L3—4   + + Teicoplanin IV
(42 days) and
meropenem IV
(14 days);
oral ciprofloxacin
for 10 months
30 35 Improved
WBC, white blood cell count; CRP, C-reactive protein (upper normal limit <1 mg/dl); ESR, erythrocyte sedimentation rate (upper normal limit < 20 mm/1 h); T, thoracic; L, lumbar; SI, signal
intensity; DE, disc enhancement; BM, bone marrow edema; VB Gado+, vertebral body enhancement after gadolinium; MRI, magnetic resonance imaging; IV, intravenous; IM, intramuscular.
Patients are numbered the same as in Table 1.
a There was worsening of all imaging findings except epidural and paraspinal infection, which were improved.
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causative agents
Plain films of the spine were not helpful. Technetium bone
scans (Tc-99m-MDP), demonstrated abnormalities suggestive
of infection in all of the patients; three patients initially
underwent computed tomography (CT) scans of the lumbar
spine; one study was negative. Using MRI studies we identi-
fied 12 anatomical levels of infection (Table 2).
The causative organism was identified in 7/8 (87.5%)
patients. In four patients Staphylococcus aureus was identi-
fied, while Brucella melitensis, Pseudomonas aeruginosa,
and a double infection due to Enterococcus faecalis and
Escherichia coli were identified in the remaining three
patients (Table 2). Patients 1, 3, 4, 6, and 7 had both epidural
and paraspinal infections. Canal stenosis (%) was observed by
MRI in patients 1, 4, and 7 (<25%) and patient 6 (>25%). The
most likely portal of entry in cases with Staphylococcus
aureus was the skin (particularly via crevices between theFigure 2 Follow-up MRI at 6 weeks from patient 6: sagittal T2 (a),
show improvement of the intervertebral disc signal on T2 images, mo
more extensive post-gadolinium enhancement of the vertebral body a
paraspinal abscesses.
Figure 1 Initial MRI from patient 6: sagittal T2 (a), T1 (b), and pos
signal of the L3—L4 intervertebral disc (arrow), bone marrow edema
the vertebral body. There is paraspinal infection and extension of the
canal stenosis (arrowhead).toes). The patient with brucellosis was a stockbreeder and
had a positive history for contracting brucella — ingestion of
unpasteurized dairy products and unsafe daily practices
during his work, as he did not usually wear gloves when
milking and shearing his animals or when lambing. In patient
5, we speculate that infection with Pseudomonas aeruginosa
was due to a urinary infection as the same bacterium was
identified in urine and blood cultures. Patient 8 with the
double infection was suffering a urinary infection and spon-
taneous bacterial peritonitis due to the underlying decom-
pensated cirrhosis, from which the bacteria disseminated
hematogenously to the spine. No causative agent was iden-
tified in patient 1 as she had been treated previously with
antibiotics. The diagnosis in this patient was based on the
clinical features, the typical MRI findings, and the exclusion
of other pathologies, as well as on the favorable outcome
after antibiotic treatment with sharp response of the inflam-
matory markers and full clinical and MRI recovery followed by
complete mobilization.T1 (b), and post-gadolinium sagittal (c) and axial (d) T1 images
re extensive bone marrow edema of the L3—L4 vertebral bodies,
nd the intervertebral disc, but improvement of the epidural and
t-gadolinium sagittal (c) and axial (d) T1 images show increased
of the adjacent vertebral bodies, and contrast enhancement of
infection to the epidural space up to the level of T11, producing
Figure 3 Follow-up MRI at 12 months from patient 6: sagittal T1 before (a) and after (b) contrast administration and T2 images (c).
There are no signs of infection.
568 E. Kapsalaki et al.Patients 3, 4, 5, 6, and 8 completed antibiotic treatment,
while the other three patients were still receiving antibiotics
per os at the time of last follow-up in order to complete 10—
12 months of treatment.
Management and follow-up of the patients
None of the patients needed a surgical intervention. All
patients treated initially with intravenous antibiotics were
then switched to an oral combination (usually ciprofloxacin
and rifampin) (Table 2). One patient received vancomycin
empirically against a possible infection due to Staphylococ-
cus aureus as she suffered from scabies.
Bone marrow edema and increased T2 signal of the inter-
vertebral disc persisted even at the 6-month follow up MRI
(5/10 levels affected in patients who had completed 6
months of treatment) and 12-month MRI (3/6 levels affected
in patients who had completed 12 months of treatment),
though there was not any clinical or laboratory evidence of
persistent disease. MRI imaging findings at presentation, at 6
weeks, and at 12 months from a representative case (patient
6) are shown in Figures 1—3.
Discussion
This study presents the whole epidemiological, clinical,
laboratory, imaging, and long-term follow-up data, as well
as the outcome in a group of eight patients with spontaneous
spondylodiscitis. Back pain was the hallmark clinical mani-
festation of the disease (100%) irrespective of the causative
microorganism.2,7—9 Duration of symptoms and signs ranged
from 14 to 45 days in 7/8 patients, with the exception of 3
months in one patient, which may reflect the under-diagnosis
of this disease, as the clinical picture is quite non-specific
leading to difficulties in its timely diagnosis, at least at the
first medical evaluation.10—15 Laboratory work-up revealedan acute phase response (elevated ESR, CRP, and leukocy-
tosis) in most of our patients at the time of diagnosis.
The rate of positive blood cultures is around 50%, but it
may be even lower.1,2,7 Of note, all but one patient in our
study had a positive blood culture. Spontaneous pyogenic
spondylodiscitis usually spreads hematogenously from infec-
tions of the skin, subcutaneous tissues, and urinary tract.16
Numerous underlying risk factors have been associated with
the disease, such as diabetes mellitus, intravenous drug
abuse, catheter-associated infections, surgical interven-
tions, infective endocarditis, urinary tract infections,
chronic alcoholism, and immunocompromised states.2,9
Our report appears to support a relationship of diabetes
mellitus with the development of spondylodiscitis.17
Radiological evaluation of patients byMRI appears to be the
method of choice for detecting lesions of spondylodiscitis,
particularly at the initial stages, showing as bone marrow
edema, increased signal of the intervertebral disc on T2
images, and enhancement of the disc and the vertebral body
after gadolinium administration.1,2,7,18,19 However, we
observed a lack of correlation between long-term follow-up
MRI studiesandthe favorable treatmentoutcomeofpatients.20
Concerning the therapeutic strategy for spondylodiscitis,
there is no clear consensus, as so far no randomized clinical
trials of short-course or oral antibiotic regimens have been
published.1,2,7,12,15 As a result, the duration of antibiotic
treatment varies widely both between and within cen-
ters.3,12,15 Antibiotics are usually given intravenously for
4—6 weeks, including regimens against Staphylococcus aur-
eus and possibly against Gram-negative bacteria until suffi-
cient clinical improvement has been achieved, and CRP and
ESR levels are reduced.21 An additional oral course of at least
6 weeks is usually recommended.15,22 However, even longer
therapy may be needed because of delays in diagnosis result-
ing in the infection being similar to chronic osteomyelitis and
where 6—8 weeks of therapy do not suffice.
Spontaneous spondylodiscitis: presentation, risk factors, diagnosis, management, and outcome 569In conclusion, our data suggest that infectious discitis
should be considered in any patient with localized pain at
any level of the spine, and especially in those who suffer from
diabetesmellitus, andwhere their symptomsareaccompanied
by fever and indicators of an acute phase response. MRI has
very good sensitivity, specificity, and diagnostic accuracy for
confirming the clinical diagnosis andmay be a valuable tool for
the evaluation of treatment efficacy, though clinical improve-
ment appears not always to correlatewith the improvement in
imaging findings. Early detection of the disease is important to
avoid surgical interventions and in terms of prognosis as this
condition is characterized by prolonged hospitalization and
long-standing immobilization.23
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